- Rep. Tim Murphy: GOP knew HealthCare.gov would be an ‘unmitigated disaster’
- Political speak: Planned Parenthood dumps ‘pro-choice’ for ‘women’s health’
- U.S. attorney warns Cuomo not to interfere with anti-corruption probes
- Investigators reach Ukraine jet crash site
- Ohio gives Obama a thumbs down; Hillary Clinton tops GOP all-stars: poll
- Jesse Ventura suggests suit not over; HarperCollins could be next
- ‘No American is proud’ of certain CIA tactics: State Department
- Drug-filled drone crash outside S.C. prison sends police on alert
- GOP to Obama: Take your ‘golf cap off’ and get down to coal country
- Hamas cleric tells Jews: ‘We will exterminate you’
Obama administration to appeal Plan B contraception age limit
Question of the Day
The Obama administration, under massive pressure from both sides of the culture war over contraception, has decided to appeal a federal court’s order to make a morning-after pill available to everyone without a prescription, just a day after expanding access to the pills for younger teenage girls.
On Wednesday evening, Justice Department officials said they had filed the appeal with the 2nd U.S. Circuit Court of Appeals and also asked a district court to put on hold the early April ruling by Judge Edward Korman of New York that the administration must make Plan B One-Step available without restrictions.
In filing notice with the appeals court, Justice said Judge Korman exceeded his authority in ordering that Plan B and a generic equivalent must be sold to everybody like aspirin by May 5.
“The public interest will not be served by reclassification of drugs as non-prescription by order of a court, without appropriate agency decision-making procedures being followed,” U.S. Attorney Loretta E. Lynch said in a letter to Judge Korman, noting that the government wants to “prevent public uncertainty regarding the status of the drugs at issue.”
“Moreover, if the status of these drugs is changed and later reversed, it can lead to situations in which women mistakenly believe that they can obtain the drug without a prescription or at certain locations where it used to be, but is no longer, available,” Ms. Lynch wrote. “Depending on the outcome of the appeal, the problem would be exacerbated because products with incorrect labeling will presumably remain on pharmacy shelves.”
The appeal was filed one day after the Food and Drug Administration moved to let girls as young as 15 obtain Plan B One-Step, one of the three types of emergency contraception, without a prescription. The current age limit is 17.
Ms. Lynch said the FDA did not make the change as a direct response to the federal case, but noted that all of the plaintiffs in the pending civil case were at least 15, so none of them would be injured by the decision to cut off access at that age.
The White House said Wednesday, before Justice announced its appeal, that the decision was made entirely by FDA officials.
“This is a decision that the FDA made, and that is appropriate because it’s an independent agency,” White House press secretary Jay Carney said Wednesday. “The president, the White House, did not weigh in on this decision.”
FDA officials said they were just approving a request by the drug’s manufacturer, Teva Women’s Health Inc., and that the decision had nothing to do with the New York case.
That case puts the administration on tenuous ground with both its traditional allies and nemeses in the battle over abortion.
Conservative groups say the government is usurping the role of parents, while groups such as the Planned Parenthood Federation of America and the National Organization for Women say the administration is ignoring scientific evidence that the pill is suitable for all ages.
Judge Edward Korman rebuked Health and Human Services Secretary Kathleen Sebelius for making an “obviously political” decision in 2011 — one year before Mr. Obama’s re-election — to prohibit the sale of Plan B One-Step and its generic forms to girls younger than 17 unless they had a prescription.
Mr. Carney said the president supported Mrs. Sebelius’ decision, which was based on a lack of data regarding the pill’s effects on “younger girls and teens of reproductive age.”
The spokesman drew a distinction between Tuesday’s FDA approval and the judge’s 2011 decision, which was based on “the proposition that this medication could be made available to anyone of any age.”
© Copyright 2014 The Washington Times, LLC. Click here for reprint permission.
About the Author
Tom Howell Jr. covers politics for The Washington Times. He can be reached at firstname.lastname@example.org.
- U.S. attorney warns N.Y. Gov. Andrew Cuomo not to interfere with anti-corruption probes
- Russians are unfazed by the West's response to Putin's actions in Ukraine: poll
- Rep. Tim Murphy: GOP knew HealthCare.gov would be an 'unmitigated disaster'
- Ohio gives Obama a thumbs down, yet Hillary Clinton tops GOP all-stars: poll
- U.S. woman with Ebola is stable, improving, son says
Latest Blog Entries
TWT Video Picks
By Ted Cruz
Israel saves its enemies; Hamas endangers its friends
- Al Gore's climate-changers at EPA hearings foiled by cool temperatures
- Geraldo Rivera: Matt Drudge 'doing his best to stir up a civil war'
- Chicken pox outbreak puts illegal immigrant facility on lockdown
- GOP report sees ties between rich donors, green 'nonprofits'
- NAPOLITANO: Is the president incompetent or lawless?
- Lois Lerner hated conservatives, new emails show
- EDITORIAL: The real Lois Lerner exposed in newly released emails
- House votes to sue President Obama over claims of presidential power
- Catholic League slams Obama: 'Do Christian lives mean so little to you?'
- 'Big Bang' star Mayim Bialik helps send bulletproof vests to IDF
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world